Skip to main navigation
Skip to search
Skip to main content
Sefako Makgatho Health Sciences University Home
Search content at Sefako Makgatho Health Sciences University
Home
Profiles
Departments
Research output
Activities
Mental health update – update on depression with a focus on escitalopram
P. P. Skosana
*
, N. Shirindza
,
V. Abraham
*
Corresponding author for this work
Public Health Pharmacy and Management
Pharmacy Practice
Research output
:
Contribution to journal
›
Review article
›
peer-review
2
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Mental health update – update on depression with a focus on escitalopram'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Mental Health
100%
Escitalopram
100%
Sub-Saharan Africa
33%
Antidepressants
33%
World Health Organization
33%
Selective Serotonin Reuptake Inhibitors
33%
Disease Burden
33%
Untreated Depression
33%
Neurotransmitters
33%
Sleep Problems
33%
Non-pharmacological Treatment
33%
Emotional Health
33%
Major Depressive Disorder
33%
Depression Level
33%
Depression Disorder
33%
Worthlessness
33%
Physical Health Problems
33%
Individual Life
33%
HPA Axis
33%
Total Burden
33%
International Classification of Diseases
33%
ICD-11
33%
Behavioral Health Disorders
33%
Emotional-behavioral
33%
Potential Pathogenesis
33%
Concentration Difficulties
33%
Medicine and Dentistry
Mental Health
100%
Diseases
100%
Escitalopram
100%
Pathogenesis
66%
Major Depressive Episode
33%
Antidepressant
33%
Neurotransmitter
33%
Pharmacological Treatment
33%
Emotional Stability
33%
Emotions
33%
ICD-11
33%
Genetics
33%
Neurodevelopmental Disorder
33%
Selective Serotonin Reuptake Inhibitor
33%
International Classification of Diseases
33%
Hypothalamic-Pituitary-Adrenal Axis
33%
Nursing and Health Professions
Mental Health
100%
Escitalopram
100%
Diseases
66%
Pathogenesis
66%
Disease Burden
33%
Selective Serotonin Reuptake Inhibitor
33%
Major Depression
33%
Antidepressant
33%
World Health Organization
33%
Mental Diseases
33%
Emotions
33%
ICD-11
33%
Neurotransmitter
33%
International Classification of Diseases
33%
Pharmacology, Toxicology and Pharmaceutical Science
Escitalopram
100%
Diseases
100%
Pathogenesis
66%
Selective Serotonin Reuptake Inhibitor
33%
Antidepressant
33%
International Classification of Diseases
33%
Neurotransmitter
33%
Major Depression
33%
Mental Diseases
33%
ICD-11
33%
Neuroscience
Escitalopram
100%
Antidepressant
33%
Neurotransmitter
33%
Major Depressive Disorder
33%
Hypothalamic-Pituitary-Adrenal Axis
33%
Selective Serotonin Reuptake Inhibitor
33%
Genetics
33%
Psychopathology
33%